A Positron Emission Tomography (PET) Study to Assess the Degree of Dopamine-2 (D2) Receptor Occupancy in the Human Brain After Single Doses of BL-1020 or Perphenazine in Healthy Male Subjects Using [11C]Raclopride as PET Tracer
Clinical trial NCT00480246 · COMPLETED
Trial details
- NCT number
- NCT00480246
- Sponsor
- BioLineRx, Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.